Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics.The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns.
Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers.FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies.
The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications.It utilizes third parties for development and commercialization of its novel products.
FTL is headquartered in Brisbane, Queensland, Australia.
Factor Therapeutics Ltd (FTT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Wounds - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Pipeline Review, H1 2020, provides an overview of the Wounds (Dermatology) pipeline landscape. Wound is a breakdown in the protective function of the skin (the loss of continuity...
Wound Closure Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Wound Closure Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products...
Tissue Sealants - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Tissue Sealants - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Tissue Sealants pipeline products with comparative analysis of the products at various stages...
The Global Gene Therapy Partnering Agreements 2014-2020 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
Non Receptor Tyrosine Protein Kinase TYK2 - Pipeline Review, H1 2020 Summary Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 184.108.40.206) – Non-receptor tyrosine-protein kinase TYK2 is an enzyme encoded by the TYK2 gene. It is involved in intracellular signal transduction by involving in the initiation...
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2020" provides an overview of Amyotrophic Lateral Sclerosi Clinical trials scenario.This report provides top line data relating...